What is it about?

Demonstrates that kidneys can be transplanted across incompatible bood groups without giving patients extra anti-rejection therapy. Only additional necessary treatment is removing the antibody shortly before and after the transplant.

Featured Image

Why is it important?

Makes it safer. We achieved results the same as for our standard kidney transplant patients and without the complications reported by many.

Read the Original

This page is a summary of: ABO-INCOMPATIBLE RENAL TRANSPLANTATION WITHOUT SPLENECTOMY OR RITUXIMAB – A LOW RATE OF COMPLICATIONS, Transplantation, July 2008, Wolters Kluwer Health,
DOI: 10.1097/01.tp.0000330967.09342.85.
You can read the full text:

Read

Contributors

The following have contributed to this page